DE69603615T2 - Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie - Google Patents
Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapieInfo
- Publication number
- DE69603615T2 DE69603615T2 DE69603615T DE69603615T DE69603615T2 DE 69603615 T2 DE69603615 T2 DE 69603615T2 DE 69603615 T DE69603615 T DE 69603615T DE 69603615 T DE69603615 T DE 69603615T DE 69603615 T2 DE69603615 T2 DE 69603615T2
- Authority
- DE
- Germany
- Prior art keywords
- gene therapy
- neurogen
- ignition
- receptor antagonists
- neurogenic inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US500295P | 1995-10-10 | 1995-10-10 | |
US634495P | 1995-11-07 | 1995-11-07 | |
PCT/IB1996/001042 WO1997013514A1 (en) | 1995-10-10 | 1996-10-02 | Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69603615D1 DE69603615D1 (de) | 1999-09-09 |
DE69603615T2 true DE69603615T2 (de) | 2000-02-17 |
Family
ID=26673771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69603615T Expired - Fee Related DE69603615T2 (de) | 1995-10-10 | 1996-10-02 | Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie |
Country Status (9)
Country | Link |
---|---|
US (1) | US6562335B1 (de) |
EP (1) | EP0854720B1 (de) |
JP (1) | JP3041051B2 (de) |
AT (1) | ATE182788T1 (de) |
CA (1) | CA2228572C (de) |
DE (1) | DE69603615T2 (de) |
ES (1) | ES2134639T3 (de) |
GR (1) | GR3031758T3 (de) |
WO (1) | WO1997013514A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1067051C (zh) * | 1998-06-05 | 2001-06-13 | 中国科学院广州化学研究所 | 一种制备桥环二元酸酐二酯的方法 |
CA2422613A1 (en) * | 2000-09-26 | 2003-03-14 | Tanabe Seiyaku Co., Ltd. | 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof |
EP2117538A1 (de) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmazeutische zusammensetzungen mit 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000331A1 (en) | 1991-06-20 | 1993-01-07 | Pfizer Inc. | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
US6048859A (en) * | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
NZ267209A (en) | 1993-05-06 | 1997-09-22 | Merrell Dow Pharma | Substituted pyrrolidin-3-yl-alkyl-piperidine derivatives, preparation and pharmaceutical compositions thereof |
US5703065A (en) * | 1993-09-17 | 1997-12-30 | Pfizer Inc. | Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds |
US5872154A (en) * | 1995-02-24 | 1999-02-16 | The Trustees Of The University Of Pennsylvania | Method of reducing an immune response to a recombinant adenovirus |
US5993800A (en) * | 1995-06-05 | 1999-11-30 | Bristol-Myers Squibb Company | Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand |
-
1996
- 1996-10-02 JP JP9514868A patent/JP3041051B2/ja not_active Expired - Fee Related
- 1996-10-02 WO PCT/IB1996/001042 patent/WO1997013514A1/en active IP Right Grant
- 1996-10-02 AT AT96931199T patent/ATE182788T1/de not_active IP Right Cessation
- 1996-10-02 ES ES96931199T patent/ES2134639T3/es not_active Expired - Lifetime
- 1996-10-02 DE DE69603615T patent/DE69603615T2/de not_active Expired - Fee Related
- 1996-10-02 EP EP96931199A patent/EP0854720B1/de not_active Expired - Lifetime
- 1996-10-02 CA CA002228572A patent/CA2228572C/en not_active Expired - Fee Related
-
1998
- 1998-05-18 US US09/077,045 patent/US6562335B1/en not_active Expired - Fee Related
-
1999
- 1999-11-04 GR GR990402849T patent/GR3031758T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH10511119A (ja) | 1998-10-27 |
CA2228572C (en) | 2003-07-22 |
EP0854720A1 (de) | 1998-07-29 |
US6562335B1 (en) | 2003-05-13 |
CA2228572A1 (en) | 1997-04-17 |
GR3031758T3 (en) | 2000-02-29 |
WO1997013514A1 (en) | 1997-04-17 |
EP0854720B1 (de) | 1999-08-04 |
ES2134639T3 (es) | 1999-10-01 |
JP3041051B2 (ja) | 2000-05-15 |
DE69603615D1 (de) | 1999-09-09 |
ATE182788T1 (de) | 1999-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT97615A (pt) | Metodo para atingir um efeito terapeutico sinergistico com composicoes terapeuticas contendo pelo menos dois agentes terapeuticos seleccionados a partir de um inibidor de renina, um inibidor de enzima de conversao de angiotensina i e um antagonista de angiotensina ii | |
MX9708780A (es) | Nuevos heterociclos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4. | |
TR199900326T2 (xx) | �st solunum yollar� alerjik tepkisinin histamin resept�r antagonistlerin bir birle�imi ile tedavisi. | |
EA200000080A1 (ru) | 1-аминоалкилциклогексановые антагонисты рецепторов nmda | |
MY131434A (en) | Angiotensin ii antagonists | |
ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
TR199802698T2 (xx) | Valsartan�n kat� oral doz formlar�. | |
DK0850221T3 (da) | Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister | |
DE69526677T2 (de) | Aromatische heterocyclische derivate als enzyminhibitoren | |
MY116002A (en) | Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis | |
ATE194141T1 (de) | Tricyclische substituierte hexahydrobenz(e)isoindol alpha-1-adrenergische antagonisten | |
DE69413237T2 (de) | Plättchenaggregationsinhibitoren | |
SE9301667D0 (sv) | New use | |
NO963064D0 (no) | Behandling av normotensive glaukoma med angiotensin-II-antagonister | |
SG188700A1 (en) | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors | |
MY106159A (en) | Substituted n-(imidazolyl)alkyl alanine derivatives. | |
DE69330754D1 (de) | 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINE ALS NMDA REZEPTOR ANTAGONISTEN | |
WO1991009593A3 (en) | 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability | |
ATE211737T1 (de) | Tricyclisch substituierte 2,4-dithi(oxo)- pyrimidin-5-yl-verbindungen als p2- purinoceptor- antagonisten | |
DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
BR9809848A (pt) | Composição | |
DE69603615T2 (de) | Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie | |
ATE235468T1 (de) | Plättchenaggregationsinhibitoren | |
ATE330599T1 (de) | Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt | |
FI941118A (fi) | Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |